Approximately 90% of hEDS patients suffer from GI challenges like reflux, gastroparesis, and irritable bowel syndrome (IBS)
renhet 2026 4,8 ProvenExpert The CJC-1295/Ipamorelin Blend pairs two complementary growth hormone (GH) secretagogues in a single vial: 5 mg of CJC-1295 without DAC (also known as Modified GRF 1-29), a short-acting analog of growth hormone-releasing hormone (GHRH), and 5 mg of Ipamorelin, a highly selective growth hormone-releasing peptide (GHRP) and ghrelin-receptor mimetic
These medications work by mimicking incretin hormones, which enhance insulin secretion, suppress glucagon release, and significantly reduce appetite through delayed gastric emptying and central nervous system effects
The problem is keeping athletes consistent
BMP, bone morphogenetic protein
Promotes p450 phase II conjugation pathways in the liver to support detoxification*